BUCHI J KEVIN
Transaction: 06/29/2026
SELL
Change
-51,813
Price
Not reported
Filing
06/30/2026
Type
SELL
Benitec Biopharma Inc.
BNTC • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$334.95M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 42.5%Manageable debt level · 0Healthy liquidity · 34Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Sep 30, 2026, 12:07 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$334.95M
52W Range9.26 - 16.76
Beta0.27
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio34.00
Quick Ratio34.00
Revenue 5Y-100.00%
Price$0.00
Change0.00%
Market Cap$334.95M
52W Range9.26 - 16.76
Beta0.27
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio34.00
Quick Ratio34.00
Revenue 5Y-100.00%
Target$21.00
Target Median$21.00
Target Range17.00 - 25.00
Volume110.97K
Avg Volume139.43K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
52
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
74/100
Why this score▼
Positive revenue growth · 42.5%Manageable debt level · 0Healthy liquidity · 34Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-09-30
Low
$17.00
Mean
$21.00
Median
$21.00
High
$25.00
Insider Transactions
Recent executive and insider activity
Friedman David Matthew
Transaction: 05/26/2026
BUY
Change
+35,000
Price
$11.45
Filing
05/28/2026
Type
BUY
Friedman David Matthew
Transaction: 05/22/2026
OTHER
Change
0
Price
Not reported
Filing
05/28/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| BUCHI J KEVIN | SELL | -51,813 | Not reported | 06/29/2026 | 06/30/2026 |
| Friedman David Matthew | BUY | +35,000 | $11.45 | 05/26/2026 | 05/28/2026 |
| Friedman David Matthew | OTHER | 0 | Not reported | 05/22/2026 | 05/28/2026 |
| Mates Sharon | BUY | +31,500 | $12.83 | 01/22/2026 | 01/26/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | BUY | +11,587 | $13.44 | 12/29/2025 | 12/29/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | BUY | +2,516 | $13.10 | 12/26/2025 | 12/29/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | BUY | +7,400 | $12.85 | 12/23/2025 | 12/29/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | BUY | +2,892 | $12.08 | 12/22/2025 | 12/22/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | BUY | +2,434 | $11.48 | 12/19/2025 | 12/22/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | BUY | +1,515 | $11.24 | 12/18/2025 | 12/22/2025 |
| BUCHI J KEVIN | BUY | +35,000 | $12.23 | 12/01/2025 | 12/03/2025 |
| Francis Peter | BUY | +35,000 | $12.23 | 12/01/2025 | 12/03/2025 |
| Smith Edward F | BUY | +35,000 | $12.23 | 12/01/2025 | 12/03/2025 |
| Mehta Kishan | BUY | +35,000 | $12.23 | 12/01/2025 | 12/03/2025 |
| Mates Sharon | BUY | +3,500 | $12.23 | 12/01/2025 | 12/03/2025 |
| Boston Megan | BUY | +200,000 | $13.53 | 11/18/2025 | 11/20/2025 |
| Banks Jerel A. | BUY | +450,000 | $13.53 | 11/18/2025 | 11/20/2025 |
| Mukadam Sophie | BUY | +500,000 | $13.53 | 11/18/2025 | 11/20/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | BUY | +751,111 | $13.50 | 11/07/2025 | 11/10/2025 |
| Mates Sharon | BUY | +28,517 | $15.78 | 11/05/2025 | 11/07/2025 |